Literature DB >> 27725860

MicroRNA-561 inhibits gastric cancercell proliferation and invasion by downregulating c-Myc expression.

Kun Qian1, Binglang Mao2, Wei Zhang1, Huanwen Chen3.   

Abstract

Gastric cancer (GC) causes nearly one million deaths worldwide each year. However, the molecular pathway of GC development remains unclear. Increasing evidences have shown that microRNAs (miRNAs) are highly associated with tumor development. However, relative little is known about the potential role of miRNAs in gastric cancer development. In the present study, we showed that miR-561 was down-regulated frequently in human GCs cell lines and tissues, and its expression was associated with tumor-node-metastasis (pTNM) stage. Enforced expression of miR-561 in GC cells inhibited cell proliferation and invasion in vitro. In contrast, knockdown of miR-561 had the opposite effect on cell proliferation and invasion. Moreover, c-Myc was identified as a potential miR-561 target. Further studies confirmed that miR-561 suppressed the expression of c-Myc by directly binding to its 3'-untranslated region. Restoration of c-Myc in miR-561-overexpressed GC cells reversed the suppressive effects of miR-561 and c-Myc was inversely correlated with miR-561 expression in GC tissues. These results demonstrate that miR-561 acts as a novel tumor suppressor in GC by targeting c-Myc gene and inhibiting GC cells proliferation and invasion. These findings contribute to current understanding of the functions of miR-561 in GC.

Entities:  

Keywords:  Gastric cancer; c-Myc; microRNA-561; tumor suppressor

Year:  2016        PMID: 27725860      PMCID: PMC5040678     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  39 in total

Review 1.  The complexities of microRNA regulation: mirandering around the rules.

Authors:  Kimberly Breving; Aurora Esquela-Kerscher
Journal:  Int J Biochem Cell Biol       Date:  2009-09-30       Impact factor: 5.085

2.  Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C.

Authors:  Qiaoyuan Yang; Zhigang Jie; Hong Cao; Anne R Greenlee; Chengfeng Yang; Fei Zou; Yiguo Jiang
Journal:  Carcinogenesis       Date:  2011-02-24       Impact factor: 4.944

3.  MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors.

Authors:  Wajana L Labisso; Matthias Wirth; Natasa Stojanovic; Roland H Stauber; Angelika Schnieke; Roland M Schmid; Oliver H Krämer; Dieter Saur; Günter Schneider
Journal:  Cell Cycle       Date:  2012-04-15       Impact factor: 4.534

4.  A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population.

Authors:  Fengying Zhou; Haixia Zhu; Dewei Luo; Meilin Wang; Xiao Dong; Yan Hong; Bo Lu; Yan Zhou; Jianwei Zhou; Zhengdong Zhang; Weida Gong
Journal:  DNA Cell Biol       Date:  2012-03-28       Impact factor: 3.311

Review 5.  Incidence and mortality of gastric cancer in China.

Authors:  Ling Yang
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

6.  Effects of combined c-myc and Bmi-1 siRNAs on the growth and chemosensitivity of MG-63 osteosarcoma cells.

Authors:  Xiankuan Xie; Zhaoming Ye; Disheng Yang; Huiming Tao
Journal:  Mol Med Rep       Date:  2013-05-20       Impact factor: 2.952

7.  MicroRNA-561 promotes acetaminophen-induced hepatotoxicity in HepG2 cells and primary human hepatocytes through downregulation of the nuclear receptor corepressor dosage-sensitive sex-reversal adrenal hypoplasia congenital critical region on the X chromosome, gene 1 (DAX-1).

Authors:  Minghua Li; Yinxue Yang; Zhi-Xu He; Zhi-Wei Zhou; Tianxin Yang; Peixuan Guo; Xueji Zhang; Shu-Feng Zhou
Journal:  Drug Metab Dispos       Date:  2013-10-08       Impact factor: 3.922

8.  MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

Authors:  Anchit Khanna; Camilla Böckelman; Annabrita Hemmes; Melissa R Junttila; Jan-Patrik Wiksten; Mikael Lundin; Siina Junnila; Daniel J Murphy; Gerard I Evan; Caj Haglund; Jukka Westermarck; Ari Ristimäki
Journal:  J Natl Cancer Inst       Date:  2009-05-26       Impact factor: 13.506

9.  MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.

Authors:  Y Xu; F Zhao; Z Wang; Y Song; Y Luo; X Zhang; L Jiang; Z Sun; Z Miao; H Xu
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

10.  Amplification of both c-myc and c-raf-1 oncogenes in a human osteosarcoma.

Authors:  S Ikeda; H Sumii; K Akiyama; S Watanabe; S Ito; H Inoue; H Takechi; G Tanabe; T Oda
Journal:  Jpn J Cancer Res       Date:  1989-01
View more
  16 in total

1.  Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas.

Authors:  Yan-Zhou Song; Xu Li; Wei Li; Zhong Wang; Kai Li; Fang-Liang Xie; Feng Zhang
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

2.  Retraction: MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer.

Authors: 
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

3.  Retraction: MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3.

Authors: 
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

Review 4.  Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential.

Authors:  Dharambir Kashyap; Hardeep Singh Tuli; Vivek Kumar Garg; Neelam Goel; Anupam Bishayee
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

5.  Circular RNA circHIPK3 Activates Macrophage NLRP3 Inflammasome and TLR4 Pathway in Gouty Arthritis via Sponging miR-561 and miR-192.

Authors:  Chaofeng Lian; Jinlei Sun; Wenjuan Guan; Lei Zhang; Xin Zhang; Lu Yang; Wenlu Hu
Journal:  Inflammation       Date:  2021-06-04       Impact factor: 4.092

6.  Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.

Authors:  Jing Wang; Xiaofeng Xue; Han Hong; Mingde Qin; Jin Zhou; Qing Sun; Hansi Liang; Ling Gao
Journal:  Oncotarget       Date:  2017-01-03

7.  High Expression of long non-coding RNA PVT1 predicts metastasis in Han and Uygur Patients with Gastric Cancer in Xinjiang, China.

Authors:  Xianxian Ren; Dongdong Cao; Li Yang; Xia Li; Wei Zhang; Yongbiao Xiao; Yu Xi; Feng Li; Dongmei Li; Zemin Pan
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

8.  circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer.

Authors:  Sen Wang; Dong Tang; Wei Wang; Yining Yang; Xiaoqing Wu; Liuhua Wang; Daorong Wang
Journal:  Mol Cancer       Date:  2019-11-14       Impact factor: 27.401

9.  Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma.

Authors:  Rong Ma; Yanyun Zhao; Miao He; Hongliang Zhao; Yifan Zhang; Shuqi Zhou; Mengcong Gao; Di Di; Jue Wang; Jian Ding; Minjie Wei
Journal:  Cancer Cell Int       Date:  2019-12-30       Impact factor: 5.722

10.  MicroRNA-561 Affects Proliferation and Cell Cycle Transition Through PTEN/AKT Signaling Pathway by Targeting P-REX2a in NSCLC.

Authors:  ZiJun Liao; Qi Zheng; Ting Wei; YanBing Zhang; JieQun Ma; Zheng Zhao; HaiFeng Sun; KeJun Nan
Journal:  Oncol Res       Date:  2019-11-11       Impact factor: 5.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.